Literature DB >> 15604180

The Polymeal: a more natural, safer, and probably tastier (than the Polypill) strategy to reduce cardiovascular disease by more than 75%.

Oscar H Franco1, Luc Bonneux, Chris de Laet, Anna Peeters, Ewout W Steyerberg, Johan P Mackenbach.   

Abstract

OBJECTIVE: Although the Polypill concept (proposed in 2003) is promising in terms of benefits for cardiovascular risk management, the potential costs and adverse effects are its main pitfalls. The objective of this study was to identify a tastier and safer alternative to the Polypill: the Polymeal.
METHODS: Data on the ingredients of the Polymeal were taken from the literature. The evidence based recipe included wine, fish, dark chocolate, fruits, vegetables, garlic, and almonds. Data from the Framingham heart study and the Framingham offspring study were used to build life tables to model the benefits of the Polymeal in the general population from age 50, assuming multiplicative correlations.
RESULTS: Combining the ingredients of the Polymeal would reduce cardiovascular disease events by 76%. For men, taking the Polymeal daily represented an increase in total life expectancy of 6.6 years, an increase in life expectancy free from cardiovascular disease of 9.0 years, and a decrease in life expectancy with cardiovascular disease of 2.4 years. The corresponding differences for women were 4.8, 8.1, and 3.3 years.
CONCLUSION: The Polymeal promises to be an effective, non-pharmacological, safe, cheap, and tasty alternative to reduce cardiovascular morbidity and increase life expectancy in the general population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15604180      PMCID: PMC535974          DOI: 10.1136/bmj.329.7480.1447

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  18 in total

1.  Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial.

Authors:  J H John; S Ziebland; P Yudkin; L S Roe; H A W Neil
Journal:  Lancet       Date:  2002-06-08       Impact factor: 79.321

2.  Meta-analysis of wine and beer consumption in relation to vascular risk.

Authors:  Augusto Di Castelnuovo; Serenella Rotondo; Licia Iacoviello; Maria Benedetta Donati; Giovanni De Gaetano
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

3.  Chocolate and blood pressure in elderly individuals with isolated systolic hypertension.

Authors:  Dirk Taubert; Reinhard Berkels; Renate Roesen; Wolfgang Klaus
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

4.  Epidemiological approaches to heart disease: the Framingham Study.

Authors:  T R DAWBER; G F MEADORS; F E MOORE
Journal:  Am J Public Health Nations Health       Date:  1951-03

5.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

6.  A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort.

Authors:  A Peeters; A A Mamun; F Willekens; L Bonneux
Journal:  Eur Heart J       Date:  2002-03       Impact factor: 29.983

7.  Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial.

Authors:  David J A Jenkins; Cyril W C Kendall; Augustine Marchie; Tina L Parker; Philip W Connelly; Wei Qian; James S Haight; Dorothea Faulkner; Edward Vidgen; Karen G Lapsley; Gene A Spiller
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

8.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

9.  A strategy to reduce cardiovascular disease by more than 80%.

Authors:  N J Wald; M R Law
Journal:  BMJ       Date:  2003-06-28

10.  Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial.

Authors:  Joan Sabaté; Ella Haddad; Jay S Tanzman; Pera Jambazian; Sujatha Rajaram
Journal:  Am J Clin Nutr       Date:  2003-06       Impact factor: 7.045

View more
  23 in total

Review 1.  Diseases of comfort: primary cause of death in the 22nd century.

Authors:  Bernard C K Choi; David J Hunter; Walter Tsou; Peter Sainsbury
Journal:  J Epidemiol Community Health       Date:  2005-12       Impact factor: 3.710

2.  Facts and ideas from anywhere.

Authors:  William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

3.  The origins of human disease: a short story on "where diseases come from".

Authors:  Johan P Mackenbach
Journal:  J Epidemiol Community Health       Date:  2006-01       Impact factor: 3.710

4.  Population strategies to treat hypertension.

Authors:  Daniel T Lackland
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-08

Review 5.  Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

Authors:  Ehete Bahiru; Angharad N de Cates; Matthew Rb Farr; Morag C Jarvis; Mohan Palla; Karen Rees; Shah Ebrahim; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

6.  Cardiovascular risk models.

Authors:  Luc Bonneux
Journal:  BMJ       Date:  2007-07-06

7.  Population health: challenges for science and society.

Authors:  David Mechanic
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

Review 8.  Issues to consider in the pharmaceutical development of a cardiovascular polypill.

Authors:  Antonio Guglietta; Marta Guerrero
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-23

9.  Lifestyle modifications and the resolution of obstructive sleep apnea syndrome: a case report.

Authors:  Thaddeus R Gala; David R Seaman
Journal:  J Chiropr Med       Date:  2011-04-05

Review 10.  Dark chocolate: consumption for pleasure or therapy?

Authors:  Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Emmanuel J Favaloro; Gian Cesare Guidi; Giovanni Targher
Journal:  J Thromb Thrombolysis       Date:  2008-09-23       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.